Literature DB >> 25036371

Spinal cord injury causes chronic liver pathology in rats.

Andrew D Sauerbeck1, J Lukas Laws, Veera V R Bandaru, Phillip G Popovich, Norman J Haughey, Dana M McTigue.   

Abstract

Traumatic spinal cord injury (SCI) causes major disruption to peripheral organ innervation and regulation. Relatively little work has investigated these post-SCI systemic changes, however, despite considerable evidence that multiple organ system dysfunction contributes to chronic impairments in health. Because metabolic dysfunction is common after SCI and the liver is a pivotal site for metabolic homeostasis, we sought to determine if liver pathology occurs as a result of SCI in a rat spinal contusion model. Histologic evidence showed excess lipid accumulation in the liver for at least 21 days post-injury after cervical or midthoracic SCI. Lipidomic analysis revealed an acute increase in hepatic ceramides as well as chronically elevated lactosylceramide. Post-SCI hepatic changes also included increased proinflammatory gene expression, including interleukin (IL)-1α, IL-1β, chemokine ligand-2, and tumor necrosis factor-α mRNA. These were coincident with increased CD68+ macrophages in the liver through 21 days post-injury. Serum alanine transaminase, used clinically to detect liver damage, was significantly increased at 21 days post-injury, suggesting that early metabolic and inflammatory damage preceded overt liver pathology. Surprisingly, liver inflammation was even detected after lumbar SCI. Collectively, these results suggest that SCI produces chronic liver injury with symptoms strikingly similar to those of nonalcoholic steatohepatitis (fatty liver disease). These clinically significant hepatic changes after SCI are known to contribute to systemic inflammation, cardiovascular disease, and metabolic syndrome, all of which are more prevalent in persons with SCI. Targeting acute and prolonged hepatic pathology may improve recovery and reduce long-term complications after SCI.

Entities:  

Keywords:  NASH; acute phase response; cytokines; metabolic syndrome

Mesh:

Year:  2014        PMID: 25036371      PMCID: PMC4298754          DOI: 10.1089/neu.2014.3497

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  73 in total

1.  Spectral analyses of cardiovascular control in rodents with spinal cord injury.

Authors:  Jessica A Inskip; Leanne M Ramer; Matt S Ramer; Andrei V Krassioukov; Victoria E Claydon
Journal:  J Neurotrauma       Date:  2012-04-02       Impact factor: 5.269

Review 2.  Influence of the neurological level of spinal cord injury on cardiovascular outcomes in humans: a meta-analysis.

Authors:  C R West; P Mills; A V Krassioukov
Journal:  Spinal Cord       Date:  2012-03-06       Impact factor: 2.772

Review 3.  A role for sphingolipids in the pathophysiology of obesity-induced inflammation.

Authors:  Benjamin T Bikman
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

4.  The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade.

Authors:  Feng Bao; Vanessa Omana; Arthur Brown; Lynne C Weaver
Journal:  J Neurotrauma       Date:  2012-02-29       Impact factor: 5.269

Review 5.  The systemic response to brain injury and disease.

Authors:  Daniel C Anthony; Yvonne Couch; Patrick Losey; Matt C Evans
Journal:  Brain Behav Immun       Date:  2011-11-09       Impact factor: 7.217

6.  Vitamin E prevents the age-dependent and palmitate-induced disturbances of sphingolipid turnover in liver cells.

Authors:  Nataliya A Babenko; Loay Kh M Hassouneh; Vitalina S Kharchenko; Vladimir V Garkavenko
Journal:  Age (Dordr)       Date:  2011-07-28

7.  Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis.

Authors:  Susanne Schiffmann; Nerea Ferreiros; Kerstin Birod; Max Eberle; Yannick Schreiber; Waltraud Pfeilschifter; Ulf Ziemann; Sandra Pierre; Klaus Scholich; Sabine Grösch; Gerd Geisslinger
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

8.  The systemic inflammatory response after spinal cord injury damages lungs and kidneys.

Authors:  Denis Gris; Eilis F Hamilton; Lynne C Weaver
Journal:  Exp Neurol       Date:  2008-03-04       Impact factor: 5.330

9.  Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury.

Authors:  Y Maruyama; M Mizuguchi; T Yaginuma; M Kusaka; H Yoshida; K Yokoyama; Y Kasahara; T Hosoya
Journal:  Spinal Cord       Date:  2008-01-22       Impact factor: 2.772

10.  Mechanisms of ceramide-mediated neurodegeneration.

Authors:  Ming Tong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more
  30 in total

1.  Metabolomics and Precision Medicine in Trauma: The State of the Field.

Authors:  Sudha P Jayaraman; Rahul J Anand; Jonathan H DeAntonio; Martin Mangino; Michel B Aboutanos; Vigneshwar Kasirajan; Rao R Ivatury; Alex B Valadka; Olena Glushakova; Ronald L Hayes; Lorin M Bachmann; Gretchen M Brophy; Daniel Contaifer; Urszula O Warncke; Donald F Brophy; Dayanjan S Wijesinghe
Journal:  Shock       Date:  2018-07       Impact factor: 3.454

2.  Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats.

Authors:  Jennifer M Colón; Aranza I Torrado; Ámbar Cajigas; José M Santiago; Iris K Salgado; Yaría Arroyo; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2016-04-08       Impact factor: 5.269

3.  Pharmacological inhibition of TLR4 ameliorates muscle and liver ceramide content after disuse in previously physically active mice.

Authors:  Alec I McKenzie; Paul T Reidy; Daniel S Nelson; Jade L Mulvey; Nikol M Yonemura; Jonathan J Petrocelli; Ziad S Mahmassani; Trevor S Tippetts; Scott A Summers; Katsuhiko Funai; Micah J Drummond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-29       Impact factor: 3.619

4.  Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model.

Authors:  Gregory O'Connor; Elisabeth Jeffrey; Derik Madorma; Alexander Marcillo; Maria T Abreu; Sapna K Deo; W Dalton Dietrich; Sylvia Daunert
Journal:  J Neurotrauma       Date:  2018-06-07       Impact factor: 5.269

5.  CD11d integrin blockade reduces the systemic inflammatory response syndrome after traumatic brain injury in rats.

Authors:  Lynne C Weaver; Feng Bao; Gregory A Dekaban; Todd Hryciw; Sandy R Shultz; Donald P Cain; Arthur Brown
Journal:  Exp Neurol       Date:  2015-07-11       Impact factor: 5.330

6.  Traumatic spinal cord injury in mice with human immune systems.

Authors:  Randall S Carpenter; Kristina A Kigerl; Jessica M Marbourg; Andrew D Gaudet; Devra Huey; Stefan Niewiesk; Phillip G Popovich
Journal:  Exp Neurol       Date:  2015-07-17       Impact factor: 5.330

7.  Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury.

Authors:  Ryan D Fortune; Raymond J Grill; Christine Beeton; Mark Tanner; Redwan Huq; David S Loose
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

8.  Attenuating Neurogenic Sympathetic Hyperreflexia Robustly Improves Antibacterial Immunity After Chronic Spinal Cord Injury.

Authors:  Eugene Mironets; Roman Fischer; Valerie Bracchi-Ricard; Tatiana M Saltos; Thomas S Truglio; Micaela L O'Reilly; Kathryn A Swanson; John R Bethea; Veronica J Tom
Journal:  J Neurosci       Date:  2019-11-21       Impact factor: 6.167

Review 9.  The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury.

Authors:  Kristina A Kigerl; Kylie Zane; Kia Adams; Matthew B Sullivan; Phillip G Popovich
Journal:  Exp Neurol       Date:  2019-10-22       Impact factor: 5.330

Review 10.  Hepatic Nervous System in Development, Regeneration, and Disease.

Authors:  Bess M Miller; Isaac M Oderberg; Wolfram Goessling
Journal:  Hepatology       Date:  2021-08-15       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.